Corporate firms surge into Singapore's veterinary market as independents weigh options
Veterinary surgeon Ryan Leong turned down Mars' bid for his clinic, underscoring growing corporate interest in Singapore's fragmented animal-health sector.
Veterinary surgeon Ryan Leong declined Mars' proposal to purchase his Pets Avenue Veterinary Clinic and Referrals, opting to rename the practice Chiron Veterinary Referrals and retain full autonomy. His decision reflects a wider wave of corporate and private-equity acquisitions in Singapore, where about 125 clinics exist and roughly 80 % are independently owned. Mars Veterinary Health entered the market in 2020 and now operates around 19 licensed clinics, roughly one-sixth of the market, while regional players such as VetPartners, Hong Kong's Pet Space and Asia Vets Holdings have also secured local practices.
Industry experts cite increasing pet-owner expenditure on advanced diagnostics, surgery and intensive care as a driver of consolidation, offering economies of scale for larger networks. While larger groups can lower drug costs and improve procurement, concerns persist about reduced competition and higher prices; the Competition and Consumer Commission of Singapore has not opened a formal probe. Veterinarians like Patrick and Rina Maguire value independence but recognise potential benefits of corporate resources, suggesting the market may stabilise with 35-50 % corporate ownership.
Why it matters
Corporate consolidation could reshape veterinary services, influencing costs and choices for Singapore pet owners.
In this story
